Inhibition of NK cells by cancer cells from patients with CML prevented by Maxamine Sep. 26, 2000 No Comments
Phase I/II clinical trial demonstrates safety and tolerability of GVAX lung cancer vaccine Sep. 15, 2000 No Comments
Novel duocarmycin derivative suitable for use in anticancer immunoconjugates Sep. 15, 2000 No Comments
StressGen commences phase II trial of HspE7 for treatment of cervical cancer Sep. 12, 2000 No Comments
RSS